10-K: AIxCrypto pivots to RWA + EAI amid wider loss

AIxCrypto Holdings reported a $17.0M 2025 net loss, rebranded from Qualigen, raised $41M, built a $10.3M crypto treasury, and narrowed its strategy to real‑world asset tokenization and embodied AI while warning of going concern risks and heavy dilution.

Summary

• Rebranded to AIxCrypto Holdings (Nasdaq: AIXC) in November 2025 after a $40.7M September 2025 PIPE; focusing on Real-World Asset (RWA) tokenization and Embodied AI (EAI).
• 2025 net loss from continuing operations was $16.97M (vs. $6.16M in 2024); net loss attributable to shareholders was $19.53M including $2.56M deemed dividends.
• Cash and cash equivalents were $19.33M at December 31, 2025; digital assets fair value was $10.25M; stockholders’ equity was $27.95M.
• Digital asset activity in 2025: $16.5M purchases, $2.62M sales, and a $3.59M net loss on digital assets; BTC (51) and ETH (685) were the largest positions.
• Operating cash outflow was $6.95M; investing cash outflow $15.88M; financing cash inflow $40.99M in 2025.
• Significant credit loss expense of $4.20M on Marizyme notes receivable (gross $4.90M; allowance $4.56M; net $0.34M).
• General & administrative expense rose to $8.82M (from $4.20M), including ~$1.5M to IR Agency.
• Going concern emphasis: recurring losses and dependence on additional financing raise substantial doubt about continuing as a going concern.
• Strategy narrowed in February 2026: discontinuation of BesTrade and C10 products to concentrate on RWA + EAI; no material impairment expected beyond prior disclosures.
• Planned tokenization reference case: a $10.0M entrusted investment in Faraday Future (FFAI) equity anticipated to close before March 31, 2026; not yet completed and subject to regulatory/technical development.
• AIxC Hub user growth post-launch: 500,000 wallets and 200,000 daily active participants (Jan 15, 2026); surpassed 1,000,000 wallets (Feb 2, 2026).
• Subsequent dilution: in Jan–Mar 2026, 33,858 Series B Preferred converted into 15,074,611 common shares, increasing common shares outstanding by ~192%.
• Lead Investor Agreement with Faraday introduced a crypto-centric Treasury Reserve Policy and granted the Faraday-appointed Co-CEO sole access to crypto accounts, creating a disclosed single-point-of-failure risk.
• LifeSci lawsuit settled for $75,000 on October 9, 2025; SEC Wells Notices to Co-CEO and Chief Advisor in June 2025 closed with no action recommended on March 18, 2026.
• Shares outstanding were 20,234,993 as of March 23, 2026; aggregate market value of non-affiliates was ~$5.58M as of June 30, 2025.

Sentiment

Score: 3

Explanation: StockSavvy.ai views the widened loss, going concern uncertainty, material internal control weaknesses, single-point crypto custody risk, and significant dilution as outweighing early platform traction and cash raised.

Positives

• Strengthened liquidity: $19.33M cash and $10.25M digital assets at year-end 2025; stockholders’ equity of $27.95M.
• Successfully raised capital: $4.5M Series A-3 Preferred (July 28, 2025) and ~$40.7M PIPE including 39,943 Series B Preferred at $1,000/share and 337,432 common at $2.246 (Sept 29, 2025).
• Strategic focus: pivot to RWA tokenization and EAI to reduce operational complexity and align with institutional infrastructure opportunities.
• AIxC Hub early traction: >1,000,000 registered wallets by Feb 2, 2026 and strong initial daily activity.
• Settled legal exposure cost-effectively: LifeSci dispute resolved for $75,000 (vs. $503,483 initially claimed).
• SEC Wells Notices to key personnel concluded with no enforcement action recommended (Mar 18, 2026), reducing leadership overhang risk.

Negatives

• Losses widened: 2025 net loss from continuing operations of $16.97M (vs. $6.16M in 2024); net loss attributable to shareholders $19.53M.
• Going concern uncertainty flagged by auditor and management due to recurring losses and need for additional financing.
• Digital asset volatility impacted results: $3.59M net loss on digital assets in 2025.
• Large credit loss expense of $4.20M on Marizyme notes (allowance $4.56M), indicating collection risk.
• Material weaknesses in internal control over financial reporting, including IT general controls and staffing insufficiencies.
• Significant dilution risk realized: 15.07M new common shares issued from Series B conversions in Q1 2026 (~192% increase).
• Customer/platform revenues not yet material; early-stage commercialization increases execution risk.
• Supplier/partner strain: in arrears on accounts payable (~$1.26M A/P; $1.65M related party payable at year-end 2025).

Risks

• Substantial doubt about ability to continue as a going concern absent additional financing.
• Early-stage business model with no material revenue to date in RWA/EAI; potential failure to achieve user adoption or commercialization.
• Exposure to digital asset market volatility; concentrated crypto treasury strategy can materially impact results and equity value.
• Regulatory uncertainty for digital assets, tokenization, and AI systems could require costly changes or limit operations.
• Single point of failure risk: Faraday-appointed Co-CEO has sole access to crypto accounts; loss of access could be irretrievable.
• Dependence on third parties (custodians, infrastructure, Faraday partnership) for key data and deployment environments.
• Cybersecurity risks including potential loss/theft of private keys; reliance on third-party custodian controls.
• Large number of authorized but unissued shares enables future dilution without shareholder approval in some cases.
• FFAI Nasdaq bid-price deficiency notice (Mar 20, 2026) may pose liquidity/valuation risk to the planned $10M FFAI equity investment and tokenization reference case.
• Material weaknesses in internal control over financial reporting may impair timely and accurate financial reporting.

Future Outlook

Management is concentrating resources on RWA tokenization and EAI infrastructure, targeting enterprise/institutional customers with platform licensing, structuring/transaction fees, and ecosystem participation economics. A $10M Faraday Future equity position is expected to serve as a reference tokenization implementation, subject to closing and regulatory/technical readiness. Early-stage collaboration with FFAI Robotics may provide an initial EAI deployment environment, though no definitive commercial agreements are in place. The company continues to evaluate strategic options for the legacy QN-302 therapeutics asset. Guidance remains contingent on market adoption, regulatory clarity, and access to capital.

Management Comments

• Refocused the business in February 2026 on the RWA + EAI ecosystem and discontinued early proof-of-concept products (BesTrade and C10) to streamline operations.
• Positioned to be a compliant, programmable infrastructure layer connecting traditional capital markets to on-chain systems, with tokenization designed to encode compliance logic in smart contracts.
• AIxC Hub is intended to be a data engine for embodied AI models, with rapid early user growth following launch.

Industry Context

StockSavvy.ai notes accelerating institutional interest in blockchain and RWA tokenization, with on-chain RWA surpassing $20B in 2025 and forecasts of multi-trillion scaling over the next decade. Competition spans regulated tokenization platforms and crypto-native issuers; differentiation via compliance-grade infrastructure and credible hardware/data partnerships will be critical. AI agent and embodied AI markets are growing quickly, but monetization models and regulatory frameworks remain emergent.

Comparison to Industry Standards

• Against RWA/tokenization peers like Securitize, Tokeny, and Ondo Finance, AIxC is earlier-stage with no material revenue and a novel EAI linkage; its $10M FFAI reference tokenization is smaller in scale than larger asset-backed issuances seen in stablecoins and treasuries.
• Compared to MicroStrategy’s treasury strategy emphasizing concentrated BTC exposure, AIxC holds a diversified crypto basket ($10.25M fair value) but bears similar volatility exposure without offsetting operating cash flows.
• Relative to AI infrastructure companies (e.g., Nvidia ecosystem partners, Figure AI robotics pilots), AIxC’s EAI monetization depends on ecosystem traction and potential FFAI Robotics collaboration; it lags peers with established commercial agreements.
• Compliance posture (Nasdaq listing, custody via BitGo) compares favorably to offshore crypto-native competitors but increases cost and control requirements typical of U.S.-listed entities.

Management Changes

Corporate Governance

Legal Proceedings

• LifeSci Capital LLC v. AIxCrypto: filed January 29, 2025; settled October 9, 2025 for $75,000.
• SEC Wells Notices issued June 2025 to Co-CEO and Chief Advisor; on March 18, 2026, SEC staff stated it does not intend to recommend enforcement action.
• FFAI (counterparty for planned $10M investment) received Nasdaq bid-price deficiency notice on March 20, 2026, posing indirect risk to AIxC’s investment plan.

Related Party Transactions

• Lead Investor Agreement with Faraday Future: Faraday invested and gained governance rights; crypto-centric Treasury Reserve Policy adopted; Faraday-appointed Co-CEO with sole crypto account access.
• Transition Services Agreement with Faraday: approximately $1.0M charged in 2025; outstanding at year-end as related party payable.
• Compensation/consulting accruals to Faraday-affiliated executives and advisors: approximately $639,000 accrued as of December 31, 2025.
• PIPE participants included Faraday and its executives (e.g., YT Jia contributed $4,000,000; Jerry Wang contributed $200,000).
• 2024–2025 financings with Alpha Capital Anstalt and Yi Hua Chen included convertible debentures and warrants; certain instruments were treated as related-party at issuance.

Stakeholder Impact

• Shareholders: significant dilution from Series B conversions (~192% increase in common shares in Q1 2026) and potential future raises; high volatility tied to crypto treasury.
• Employees: streamlined focus on RWA/EAI may concentrate resources but headcount remains lean (10 employees as of year-end 2025).
• Customers/Partners: strategic reliance on Faraday/FFAI for data and deployment introduces counterparty and market risks (e.g., FFAI Nasdaq deficiency).
• Suppliers/Creditors: arrears to vendors and related parties could pressure terms; going concern risk may impact credit availability.
• Regulators: evolving digital asset and AI frameworks could necessitate compliance investments and product modifications.

Next Steps

• Close the entrusted $10M Faraday Future equity investment and develop its tokenization framework (anticipated by March 31, 2026, subject to conditions).
• Advance commercialization of the AIxC Hub and EAI infrastructure with enterprise licensing and ecosystem participation.
• Formalize any commercial agreements with FFAI Robotics to pilot EAI deployments (not yet definitive).
• Evaluate strategic options for QN-302, including continuing trial, licensing, or sale.
• Strengthen internal controls and cybersecurity governance; continue developing standalone cybersecurity infrastructure.
• Manage dilution and liquidity post-Series B conversions; pursue additional financing as needed.

Key Dates

Recommendation

The widened losses, going concern uncertainty, material internal control weaknesses, concentrated crypto custody risk, heavy dilution from Series B conversions, and dependence on counterparties (including FFAI’s bid-price deficiency) outweigh early traction and cash on hand. Until there is clear revenue traction and strengthened controls/governance around treasury and operations, risk-adjusted return skews negative for institutional holders.

Keywords

AIxCrypto, RWA tokenization, Embodied AI, Faraday Future, digital assets treasury, cryptocurrency, tokenization, Series B Preferred, PIPE financing, Nasdaq AIXC, AIxC Hub, BitMart, QN-302, going concern, dilution